NSE · KILITCH

Kilitch Drugs (India) Limited

Sector: Healthcare · ISIN: INE729D01010

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#1,692

of 5,096 stocks

▲ 771W

Peak #1,673 · 27 Sep 2026

Kilitch Drugs (India) Limited, a smallcap Healthcare business, remains firmly promoter-controlled, with promoters holding 64%, is growing revenue at a solid clip, and trades at a moderate earnings multiple. Ownership as of Jun 2026.

Market Cap

758.84 Cr

P/E Ratio

24.36

P/B Ratio

2.74

ROE

10.66%

ROCE

13.15%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	44.88 Cr	89.60 Cr	53.81 Cr	48.92 Cr
Net Profit	1.97 Cr	14.88 Cr	4.32 Cr	8.04 Cr
EPS	0.83	4.24	2.50	4.97
Operating Profit	4.74 Cr	21.65 Cr	6.74 Cr	10.84 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

63.77%

Public

36.23%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
24 Mar 2026	Bonus	Bonus 1:1
15 Jul 2025	Rights	Rights 2:23 @ Premium Rs 347/-
19 Sep 2024	Other	Annual General Meeting
21 Sep 2023	Other	Annual General Meeting
20 Sep 2022	Other	Annual General Meeting

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs